SUPV3L1
Basic information
Region (hg38): 10:69180234-69209099
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SUPV3L1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 40 | 41 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 40 | 3 | 0 |
Variants in SUPV3L1
This is a list of pathogenic ClinVar variants found in the SUPV3L1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
10-69180304-C-G | not specified | Uncertain significance (Feb 22, 2023) | ||
10-69180307-G-T | not specified | Uncertain significance (Feb 13, 2024) | ||
10-69180377-G-A | not specified | Uncertain significance (Oct 16, 2023) | ||
10-69180390-G-A | Likely benign (Apr 01, 2022) | |||
10-69180418-T-G | not specified | Uncertain significance (May 06, 2022) | ||
10-69180452-G-C | not specified | Uncertain significance (Dec 17, 2023) | ||
10-69180461-A-G | not specified | Uncertain significance (Nov 30, 2022) | ||
10-69180488-C-T | not specified | Uncertain significance (Aug 17, 2021) | ||
10-69180508-G-A | not specified | Uncertain significance (Aug 01, 2022) | ||
10-69186479-A-C | not specified | Uncertain significance (Oct 04, 2022) | ||
10-69186536-T-C | not specified | Uncertain significance (Dec 12, 2023) | ||
10-69186544-G-A | not specified | Likely benign (Jan 23, 2024) | ||
10-69187665-T-A | not specified | Uncertain significance (Feb 14, 2023) | ||
10-69187689-A-G | not specified | Uncertain significance (Dec 06, 2022) | ||
10-69187722-C-T | not specified | Uncertain significance (Sep 14, 2021) | ||
10-69189356-A-T | not specified | Uncertain significance (Apr 20, 2024) | ||
10-69189365-C-A | not specified | Uncertain significance (Jun 17, 2022) | ||
10-69189427-A-G | not specified | Uncertain significance (Feb 11, 2022) | ||
10-69191758-C-G | not specified | Uncertain significance (Aug 02, 2021) | ||
10-69197036-A-G | not specified | Uncertain significance (Jan 30, 2024) | ||
10-69197066-A-G | not specified | Uncertain significance (Dec 13, 2022) | ||
10-69198382-A-G | not specified | Uncertain significance (Oct 26, 2022) | ||
10-69198442-G-A | not specified | Uncertain significance (Apr 18, 2023) | ||
10-69198495-C-T | not specified | Uncertain significance (Jul 14, 2021) | ||
10-69199143-A-G | not specified | Uncertain significance (Apr 04, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SUPV3L1 | protein_coding | protein_coding | ENST00000359655 | 15 | 28868 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0320 | 0.968 | 125725 | 0 | 22 | 125747 | 0.0000875 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.15 | 364 | 431 | 0.845 | 0.0000215 | 5157 |
Missense in Polyphen | 78 | 139.24 | 0.56017 | 1729 | ||
Synonymous | -0.349 | 161 | 155 | 1.04 | 0.00000772 | 1533 |
Loss of Function | 4.07 | 10 | 36.5 | 0.274 | 0.00000203 | 435 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000116 | 0.000116 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000165 | 0.000163 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.0000621 | 0.0000615 |
Middle Eastern | 0.000165 | 0.000163 |
South Asian | 0.000235 | 0.000229 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Major helicase player in mitochondrial RNA metabolism. Component of the mitochondrial degradosome (mtEXO) complex, that degrades 3' overhang double-stranded RNA with a 3'-to-5' directionality in an ATP-dependent manner. ATPase and ATP- dependent multisubstrate helicase, able to unwind double-stranded (ds) DNA and RNA, and RNA/DNA heteroduplexes in the 5'-to-3' direction. Plays a role in the RNA surveillance system in mitochondria; regulates the stability of mature mRNAs, the removal of aberrantly formed mRNAs and the rapid degradation of non coding processing intermediates. Also implicated in recombination and chromatin maintenance pathways. May protect cells from apoptosis. Associates with mitochondrial DNA. {ECO:0000269|PubMed:12466530, ECO:0000269|PubMed:15096047, ECO:0000269|PubMed:17352692, ECO:0000269|PubMed:17961633, ECO:0000269|PubMed:18678873, ECO:0000269|PubMed:19509288, ECO:0000269|PubMed:19864255}.;
Recessive Scores
- pRec
- 0.122
Intolerance Scores
- loftool
- 0.552
- rvis_EVS
- -0.98
- rvis_percentile_EVS
- 8.85
Haploinsufficiency Scores
- pHI
- 0.266
- hipred
- Y
- hipred_score
- 0.618
- ghis
- 0.576
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.943
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Supv3l1
- Phenotype
- skeleton phenotype; immune system phenotype; hearing/vestibular/ear phenotype; digestive/alimentary phenotype; normal phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); respiratory system phenotype; embryo phenotype; cellular phenotype; craniofacial phenotype; muscle phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); endocrine/exocrine gland phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); growth/size/body region phenotype;
Zebrafish Information Network
- Gene name
- supv3l1
- Affected structure
- hepatocyte
- Phenotype tag
- abnormal
- Phenotype quality
- disorganized
Gene ontology
- Biological process
- mitochondrial mRNA catabolic process;positive regulation of mitochondrial RNA catabolic process;mitochondrial RNA 3'-end processing;DNA recombination;RNA catabolic process;positive regulation of cell growth;DNA duplex unwinding;mitochondrial ncRNA surveillance;mitochondrial mRNA surveillance;negative regulation of apoptotic process;mitochondrion morphogenesis;chromatin maintenance;mitochondrial RNA surveillance
- Cellular component
- nucleus;mitochondrion;mitochondrial matrix;mitochondrial nucleoid;mitochondrial degradosome
- Molecular function
- DNA binding;DNA helicase activity;RNA binding;double-stranded RNA binding;ATP-dependent RNA helicase activity;helicase activity;protein binding;ATP binding;3'-5' RNA helicase activity;protein homodimerization activity